Eye-Q Vision Care Offered Glaucoma Implant
Fresno clinic introduced a new FDA-approved implant to help manage glaucoma without daily eye drops.
Updated on Oct. 14, 2026 in Healthcare
Live Poll
Do you trust medical implants to manage chronic conditions more effectively than traditional self-administered treatments?
Eye-Q Vision Care in Fresno has started offering the iDose TR implant for patients with ocular hypertension and open-angle glaucoma. This medical device is designed to provide continuous medication delivery to replace the need for daily prescription eye drops.
Why it matters
The implant helps patients who struggle with the physical demands of daily drops, such as those caused by arthritis or difficulties with manual administration. It provides a consistent dosage to manage intraocular pressure and improve long-term treatment adherence.
The iDose TR implant delivers a dosage of 75 mcg of travoprost to patients. Clinical results show that 8 out of 10 patients remained free from daily eye drops one year after the procedure.
The players
Eye-Q Vision Care
This is a specialized ophthalmology clinic located in Fresno that provides advanced eye treatment services.
The details
The implant is surgically placed inside the eye to release medication steadily for up to three years. While it offers a reprieve from daily routines, common side effects include dry eye, eye pain, iris inflammation, and increased eye pressure.
Timeline
The implant is designed to release medication for three years.
Market Landscape
The adoption of the FDA-approved iDose TR implant marks a transition away from patient-administered medication regimens toward sustained-release medical devices. This allows clinics like Eye-Q Vision Care to compete by offering long-term management options that reduce reliance on traditional pharmaceutical supply chains.
Patients may find relief from the daily burden and cost of purchasing prescription eye drops by opting for this implantable procedure. Residents should consult with their ophthalmologists to determine if their specific glaucoma condition qualifies for this sustained-release treatment.
The takeaway
Patients considering this option should weigh the convenience of a drop-free routine against the potential risks of surgical implantation and known side effects. Maintaining consistent follow-up appointments is essential to monitor intraocular pressure after the device is inserted.
Further reading
Learn more about local medical services on our Fresno Healthcare page.
More information
For more information on the device, visit the Eye-Q Vision Care information portal.
Source note: This article includes information reported by ABC30 Fresno.
Live Poll
Do you trust medical implants to manage chronic conditions more effectively than traditional self-administered treatments?
